Original page: http://www.cptech.org/ip/wto/p6/cptech08302003.html CPTech Statement on WTO Deal on Exports of Medicines August 30, 2003 “Today’s decision on the implementation of paragraph 6 of the Doha Declaration on TRIPS and Public Health puts the WTO into unchartered waters. The WTO… Continue Reading →
Original page: http://www.cptech.org/ip/wto/p6/zoellick02102003.doc RECEIVED 24 FEB 2003 Executive Office of the President The United States Trade Representative Washington, DC 20508 February 10, 2003 Mr. James Love Co-Chair TACD IP-workinggroup TACD Secretariat 24 Highbury Crescent UK-London N5 1RXDear Mr. Love, Thank… Continue Reading →
Original page: http://www.cptech.org/ip/wto/p6/lamy12172002.doc Pascal Lamy Rue de la Loi,… Continue Reading →
Original: Page 1 – http://www.cptech.org/ip/health/eu/lamy2tacd20mar2002-p1.jpg Page 2 – http://www.cptech.org/ip/health/eu/lamy2tacd20mar2002-p2.jpg Note by James Love on April 1, 2002 via IP-Health email list regarding the letter below (archived link of the note here): This these are scans of Pascal Lamy’s March 20… Continue Reading →
Compulsory Licensing: Models For State Practice In Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord Prepared for the United Nations Development Programme January 21, 2001 James Love Consumer Project on Technology http://www.cptech.org Introduction.1 This note addresses… Continue Reading →
This statement was developed at the Increasing Access to Essential Drugs in a Globalised Economy Working Towards Solutions conference, which was organized by Health Action International, Médecins Sans Frontières, and Consumer Project on Technology, and took place in Amsterdam, the… Continue Reading →
Comments on Trade and Pharmaceutical Policies: A Perspective from the U.S. Consumer Movement HAI Seminar: World Trade Organization/GATT, Pharmaceutical Policies and Essential Drugs October 4, 1996 Bielefeld, Germany James Love Center for Study of Responsive Law (1) I would like… Continue Reading →
National policies and practices as regards the granting of and exceptions to patents, copyrights, and other types of intellectual property are often influenced by pressure from other countries. The United States is the most important source of pressure on intellectual… Continue Reading →
This was sent via email today. Jamie ————— May 1, 2024 Anne Yu Director for Global Pandemic Preparedness Development, Global Health and Humanitarian Response, National Security Council Staff, Executive Office of the President Dear Anne Yu, I’m guessing you are… Continue Reading →
PDF version is available here: KEI.MutuallyAgreedTerms.A_INB_9_3Rev1.22April2024draft KEI comments on six references to “mutually agreed terms” in the WHO pandemic agreement negotiating text: A/INB/9/3 Rev.1, 22 April 2024 James Love Knowledge Ecology International April 28, 2024, revised April 29, 2024 Introduction… Continue Reading →